<DOC>
	<DOCNO>NCT00800085</DOCNO>
	<brief_summary>This study establish criterion indicate short-term loss beta cell mass therefore accelerate progression towards type 1 diabetes .</brief_summary>
	<brief_title>Beta Cell Function ( Pre ) Type 1 Diabetes</brief_title>
	<detailed_description>This study establish criterion indicate short-term loss beta cell mass therefore accelerate progression towards type 1 diabetes . These criterion may help determine time point type prevention may contribute composition homogeneous group study subject ( base residual beta cell mass , homogeneous risk beta cell destruction intervention ) may lead identification functional marker could use surrogate endpoint . This may reduce number subject need treat well follow-up time necessary study significant effect test substance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>The follow group first degree relative type1 diabetes patient normal glucose tolerance OGTT ( 539 year ) include informed consent basis antibody status ( n = 40 per group ) : IA2Apositives ; Ab.positives ( positive least 2 different Abs . ( IAA , GADA and/or ICA ) and/or persistently Ab.positive 1 Abs ; persistently Ab.negatives . 40 type 1 diabetes patient follow criterion study : 1 ) age 1239 year ; 2 ) &lt; 4 week insulin treatment ; 3 ) autoAb.positive ; 4 ) polyuria since &lt; 6 month ; 5 ) &lt; 10 % weight loss last 6 month ; 6 ) inform consent . Pregnancy lactation woman Use illicit drug overconsumption alcohol ( &gt; 3 beers/day ) history drug alcohol abuse Being legally incapacitate , significant emotional problem time study , history psychiatric disorder Having receive antidepressant medication last 6 month Treatment immune modulate diabetogenic medication ( corticosteroid ) Presently participate another clinical study History illness , opinion investigator , might confound result study pose additional risk subject</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>first degree relative type 1 diabetes patient</keyword>
	<keyword>hyperglycemic clamp test</keyword>
</DOC>